Summary
The clinical course and response to therapy of seven patients with cryptococcosis and AIDS were reviewed. One patient was still in the primary stage of cryptococcosis in AIDS, i.e. the stage that is characterized by the sole cultural detection of Cryptococcus neoformans in the respiratory tract. The other six patients were in the secondary stage, where C. neoformans can be detected from the cerebrospinal fluid (CSF), blood, urine, faeces and other body sites. The main presenting features (headache, fever, nausea) were due to central nervous system involvement, although meningism and mental changes were rarely present, and CSF changes were very subtle. Treatment with amphotericin B and flucytosine was very effective, there being no more growth of fungi in cultures in most cases. Adverse reactions to the drugs used occurred frequently and consisted mainly of anaemia, hepatosis and fever. Diagnosis in the primary stage of cryptococcosis may improve the prognosis.
Similar content being viewed by others
References
Andriole VT, Kravetz HM (1962) The use of amphotericin B in man. JAMA 180:269–272
Bahls F, Sumi SM (1986) Cryptococcal meningitis and cerebral toxoplasmosis in a patient with acquired immune deficiency syndrome. J Neurol Neurosurg Psych 49:328–330
Bennett JE (1977) Flucytosine. Ann Intern Med 86:319–322
Bennett JE, Dismukes WE, Duma RJ, Medoff G, Sande MA, Gallis H, Leonard J, Fields BT, Bradshaw M, Haywood H, McGee ZA, Cate TR, Cobbs CG, Warner JF, Alling DW (1979) A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 301:126–131
Bloomfield N, Gordon MA, Elmendorf DF Jr (1963) Detection of Cryptococcus neoformans antigen in body fluids by latex particle agglutination. Proc Soc Exp Biol Med 114:64–67
Bohle C, Sinn M, Werner E, Staib F (1986) Cryptococcus neoformans — Meningoencephalitis bei AIDS. Klin Wochenschr 64:165–172
Brandriss MW, Wolff SM, Moores R, Stohlmann F (1964) Anemia induced by amphotericin B. JAMA 189:663–666
Butler WT (1966) Pharmacology, toxicity, and therapeutic usefulness of amphotericin B. JAMA 195:127–131
Centers for Disease Control (1987) Revision on the CDC surveillance case definition for acquired immunodeficiency syndrome. Morbid Mortal Weekly Rep 36:1–15
Chandler FW (1985) Pathology of the mycosis in patients with the acquired immunodeficiency syndrome (AIDS). In: McGinnes MR (ed) Current topics in medical mycology, vol 1. Springer, New York Berlin Heidelberg, pp 1–23
Diamond RD, Bennett JE (1974) Prognostic factors in cryptococcal meningitis. Ann Intern Med 80:176–181
Dismukes WE, Cloud G, Gallis HA, Kerkering TM, Medoff G, Craven PC, Kaplowitz LG, Fisher JF, Gregg CR, Bowles CA, Shadomy S, Stamm AM, Diasio RB, Kaufman L, Song SJ, Blackwelder WC (1987) Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 317:334–341
Drutz DJ, Spickard A, Rogers DE, Koenig MG (1968) Treatment of disseminated mycotic infections. Am J Med 45:405–418
Edwards VE, Sutherland JM, Tyrer JH (1970) Cryptococcosis of the central nervous system. J Neurol Neurosurg Psych 33:415–425
Giberson TP, Kalyan-Raman K (1987) Cryptococcal meningitis: initial presentation of acquired immunodeficiency syndrome. Ann Emerg Med 16:114–116
Goodman JS, Kaufman L, Koenig MG (1971) Diagnosis of cryptococcal meningitis. N Engl J Med 285:434–436
Gordin FM, Simon GL, Wofsy CB, Mills J (1984) Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 100:495–499
Grosse G, Niedobitek F, l'Age M, Staib F (1981) Chronische Lungenkryptokokkose. Dtsch Med Wochenschr 106:1035–1037
Heidemann HT, Brune KH (1987) Verhinderung der Amphotericin B — Nephrotoxizität durch parenteral verabreichtes Flucytosin. Therapiewoche 37:4158–4166
Heidemann HT, Gerkens JF, Spickard WA, Jackson EK, Branch RA (1983) Amphotericin B nephrotoxicity in humans decreased by salt repletion. Am J Med 75:476–481
Houk VN, Moser KM (1965) Pulmonary cryptococcosis. Ann Intern Med 63:583–596
Just G, Helm EB, Stille W (1986) Cryptococcus-neoformans-Infektion bei AIDS. Dtsch Med Wochenschr 111:1420–1421
Kaplan MH, Rosen PP, Armstrong D (1977) Cryptococcosis in a cancer hospital. Cancer 39:2265–2274
Kerkering TM, Duma RJ, Shodomy S (1981) The evolution of pulmonary cryptococcosis. Ann Intern Med 94:611–616
Kovacs JA, Kovacs AA, Polis M, Wright WC, Gill VJ, Tuazon CU, Gelman EP, Lane HC, Longfield R, Overturf G, Macher AM, Fauci AS, Parrillo JE, Bennett JE, Masur H (1985) Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 103:533–538
Liss HP, Rimland D (1981) Asymptomatic cryptococcal meningitis. Am Rev Respir Dis 88–89
Medoff G, Kobayashi GS (1975) Amphotericin B. JAMA 232:619–620
Meyer R, Axelrod JL (1974) Fatal aplastic anemia resulting from flucytosine. JAMA 228:1573
Miller RP, Bates JH (1969) Amphotericin B toxicity. Ann Intern Med 71:1089–1095
Perfect JR, Durck DT, Gallis HA (1983) Cryptococcemia. Medicine (Baltimore) 62:98–109
Pohle HD, Eichenlaub D (1986) ZNS-Toxoplasmose und generalisierte Kryptokokkose bei AIDS. In: Helm EB, Stille W, Vanek E (eds) AIDS II. Zuckschwerdt, Munich, pp 136–142
Pohle HD, Eichenlaub D (1987) ZNS-Toxoplasmose bei AIDS-Patienten. AIDS-Forschung 3:122–135
Sabetta JR, Andriole VT (1985) Cryptococcal infection of the central nervous system. Med Clin North Am 69:333–344
Sarosi GA, Parker JD, Doto IL, Tosh FE (1969) Amphotericin B in cryptococcal meningitis. Ann Intern Med 71:1079–1087
Staib F (1986) Detection of Cryptococcus neoformans in biopsy specimens from the spleen and the liver of AIDS patients: Critical comments. Mykosen 29:551–555
Staib F (1987) Kryptokokkose bei AIDS aus mykologisch-diagnostischer und-epidemiologischer Sicht. AIDS-Forschung 2:363–382
Staib F, Rögler G, Prüfer-Krämer L, Seibold M, Eichenlaub D, Pohle HD (1986) Disseminierte Kryptokokkose bei zwei AIDS-Patienten. Dtsch Med Wochenschr 111:1061–1065
Staib F, Seibold M, Antweiler E, Fröhlich B, Heißenhuber M, Voigt R, Winger U, Pfau H, Krumhaar D, Neusetzer H (1986) Cryptococcus neoformans bei Patienten einer Berliner Lungenklinik — Ein Beitrag zur Diagnostik und Bekämpfung der Cr. neoformans-Mykose. Prax Klin Pneumol 40:86–93
Staib F, Seibold M, Antweiler E, Fröhlich B, Weber S, Blisse A (1987) The brown colour effect (BCE) of Cryptococcus neoformans in the diagnosis, control and epidemiology of C. neoformans infections in AIDS patients. Zentralbl Bakt Hyg 266:167–177
Stockman L, Roberts GD (1982) Specificity of the latex test for cryptococcal antigen: a rapid, simple method for eliminating interference factors. J Clin Microbiol 16:965–967
Stockstill MT, Kauffman CA (1983) Comparison of cryptococcal and tuberculous meningitis. Arch Neurol 40:81–85
Tjia TL, Yoew YK, Tan CB (1985) Cryptococcal meningitis. J Neurol 48:853–858
Utz JP, Butler WT (1965) Cryptococcus-Meningitis. Dtsch Med Wochenschr 90:941–943
Utz JP, Garriques IL, Sande MA, Warner JF, Mandell GL, McGee RF, Duma RJ, Shadomy S (1975) Therapy of cryptococcosis with a combination of Flucytosin and Amphotericin B. J Infect Dis 132:368–373
Wegener HH, Staib F (1983) Tödliche Cryptococcose eines Vogelliebhabers. Ein kasuistischer Beitrag zur Pathologie, Diagnostik und Epidemiologie der Cryptococcose. Zentralbl Bakteriol Hyg 256:231–238
Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ (1986) Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Ann Intern Med 104:234–240
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weinke, T., Rögler, G., Sixt, C. et al. Cryptococcosis in AIDS patients: observations concerning CNS involvement. J Neurol 236, 38–42 (1989). https://doi.org/10.1007/BF00314216
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00314216